AstraZeneca

New hope for people who struggle with stubborn high blood pressure

Heart Disease

Breakthrough drug successfully treats hard-to-control high blood pressure

A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The drug, called baxdrostat, is being hailed as the most promising advance in hypertension management in decades.

A once-daily pill could do away with needing to inject

Obesity

Weight-loss pill passes important safety trial

Game-changing GLP-1 agonist drugs are a step closer to being available in oral pill form, with AstraZeneca revealing "encouraging data" from the Phase I safety and tolerability trial of its once-daily obesity and diabetes drug AZD5004.

Researchers studied a man who received 217 COVID vaccine doses

Infectious Diseases

What happened to the guy who had 217 COVID vaccinations

A man that police caught taking 217 doses of COVID vaccine has offered himself up to researchers for a study looking into what happens to the immune system after so many doses. The results offer surprising insight into these new mRNA vaccines.